Zusammenfassung
Die urothelialen Tumoren des Nierenbeckens und des Harnleiters unterscheiden sich in ihrem histopathologischen Phänotyp nicht von denen der Harnblase. Trotzdem ergeben sich bei differenzierter Betrachtung wesentliche tumorbiologische Aspekte: Das Ursprungsgewebe (Urothel) im oberen Harntrakt und in der Harnblase unterscheidet sich in entwicklungsgeschichtlicher Herkunft, morphologischer Differenzierung und physiologischer Funktion. Für die Tumoren des oberen Harntrakts werden spezifische Wege der Tumorpathogenese, z. B. im Rahmen des „Hereditary-nonpolyposis-colorectal-cancer“- (HNPCC-)Syndroms, und der Tumorausbreitung (intraluminale Tumorausbreitung) beschrieben. Klinisch-epidemiologische Befunde weisen auf spezifische Beziehungen zwischen den beiden Tumorlokalisationen hin.
Abstract
Urothelial tumors of the renal pelvis and the ureter do not differ from those of the urinary bladder concerning histopathological phenotypes. However, with respect to tumor biology there are relevant differences between the two tumor locations. The originating tissue (urothelium) of the bladder and of the upper urinary tract varies significantly with respect to developmental origin, morphology and physiological function. Specific pathways of tumorigenesis (e.g. hereditary non-polyposis colorectal cancer, HNPCC) and tumor propagation (seeding) are described for tumors of the upper urinary tract. Clinical epidemiological data indicate specific correlations between the two tumor locations.
Literatur
Catto JW, Azzouzi AR, Rehman I et al (2005) Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23:2903–2910
Chen T, Guo L, Zhang L et al (2006) Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics 26 [Suppl 2]:20
Hafner C, Knuechel R, Zanardo L et al (2001) Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20:4910–4915
Hartmann A (2003) Molecular changes in development and progression of urothelial carcinoma. Verh Dtsch Ges Pathol 87:172–184
Herr HW, Cookson MS, Soloway SM (1996) Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol 156:1286–1287
Hohlbrugger G (1995) The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control. J Urol 154:6–15
Holmäng S, Amsler-Nording S, Carlson K et al (2006) Completeness and correctness of renal pelvic and ureteral cancer in the Swedish Cancer Registry. J Urol 175:69–72
Liang FX, Bosland MC, Huang H et al (2005) Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol 171:835–844
Nortier J, Nortier L, Muniz Martinez MC et al (2000) Urothelial carcinoma associated with the use of a chinese herb (Aristolochia fangchi). N Engl J Med 342:1686–1692
Shafik A, Shafik I, El Sibai O, Shafik AA (2005) Changes of the urine composition during its passage through the ureter. A concept of urothelial function. Urol Res 33:426–428
Shafik A, Shafik I, El Sibai O, Shafik AA (2006) Does the composition of the voided urine reflect that of the renal pelvis? Urol Res 34:261–264
Sijmons RH, Kimeney LALM, Witjes JA, Vasen HFA (1998) Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol 160:466–470
Wright JL, Hotaling J, Porter M (2009) Predictors of upper urothelial cell carcinoma after primary bladder cancer: a population based analysis. J Urol 181:1035–1039
Yu W, Khandelwal P, Apodaca G (2009) Distinct apical and basolateral membrane requirements for stretch-induced membrane traffic at the apical surface of bladder umbrella cells. Mol Biol Cell 20:282–295
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hofstädter, F. Nierenbeckenkarzinom. Pathologe 30 (Suppl 2), 185–187 (2009). https://doi.org/10.1007/s00292-009-1220-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-009-1220-6